(S (PP (IN By) (NP (CD 2040))) (, ,) (NP (NP (JJ age-related) (JJ macular) (NN degeneration)) (PRN (-LRB- -LRB-) (NP (NNP AMD)) (-RRB- -RRB-))) (VP (MD will) (VP (VB affect) (NP (QP (RB approximately) (CD 288) (CD million)) (NNS people)) (ADVP (VBP worldwide)))) (. .))
(S (S (VP (VBG Identifying) (NP (NP (NNS individuals)) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN of) (NP (NP (NN progression)) (PP (TO to) (NP (NP (VB late) (NNP AMD)) (, ,) (NP (DT the) (JJ sight-threatening) (NN stage)) (, ,)))))))))) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (NP (NP (JJ clinical) (NNS actions)) (, ,) (PP (VBG including) (NP (NP (JJ medical) (NNS interventions)) (CC and) (NP (JJ timely) (NN monitoring)))))))) (. .))
(S (SBAR (IN Although) (S (NP (JJ deep) (NN learning)) (VP (VBZ has) (VP (VBN shown) (NP (NN promise)) (PP (IN in) (S (VP (VBG diagnosing/screening) (NP (NNP AMD)) (S (VP (VBG using) (NP (NN color) (NN fundus) (NN photographs))))))))))) (, ,) (NP (NP (PRP it))) (VP (VBZ remains) (ADJP (JJ difficult)) (S (VP (TO to) (VP (VB predict) (NP (NP (NP (NNS individuals) (POS â€º)) (NNS risks)) (PP (IN of) (NP (JJ late) (NNP AMD)))) (ADVP (RB accurately)))))) (. .))
(S (PP (IN For) (NP (DT both) (NNS tasks))) (, ,) (NP (DT these) (JJ initial) (NN deep) (NN learning) (NNS attempts)) (VP (VBP have) (VP (VBN remained) (ADJP (RB largely) (JJ unvalidated)) (PP (IN in) (NP (JJ independent) (NNS cohorts))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (WHADVP (WRB how)) (S (NP (NP (JJ deep) (NN learning)) (CC and) (NP (JJ survival) (NN analysis))) (VP (MD can) (VP (VB predict) (NP (NP (DT the) (NN probability)) (PP (IN of) (NP (NP (NN progression)) (PP (TO to) (NP (VB late) (NNP AMD)))))) (S (VP (VBG using) (NP (NP (CD 3,298) (NNS participants)) (PRN (-LRB- -LRB-) (NP (QP (IN over) (CD 80,000)) (NNS images)) (-RRB- -RRB-)) (PP (IN from) (NP (NP (DT the) (JJ Age-Related) (NNP Eye) (NNP Disease) (NNP Studies) (NNP AREDS) (CC and) (NNP AREDS2)) (, ,) (NP (NP (DT the) (JJS largest) (JJ longitudinal) (JJ clinical) (NNS trials)) (PP (IN in) (NP (NNP AMD)))))))))))))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (VP (VBN validated) (PP (IN against) (NP (NP (DT an) (JJ independent) (NN test) (NN dataset)) (PP (IN of) (NP (CD 601) (NNS participants)))))))) (, ,) (NP (PRP$ our) (NN model)) (VP (VBN achieved) (NP (NP (JJ high) (JJ prognostic) (NN accuracy)) (PRN (PRN (-LRB- -LRB-) (NP (JJ five-year) (JJ C-statistic) (CD 86.4)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 95) (NN %)) (NN confidence) (JJ interval)) (NP (JJ 86.2-86.6))) (-RRB- -RRB-))) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (VP (ADVP (RB substantially)) (VBD exceeded) (NP (NP (IN that)) (PP (IN of) (NP (NP (JJ retinal) (NNS specialists)) (VP (VBG using) (NP (NP (CD two) (VBG existing) (JJ clinical) (NNS standards)) (PRN (-LRB- -LRB-) (NP (NP (NP (NP (CD 81.3)) (PRN (-LRB- -LRB-) (NP (CD 81.1-81.5)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 82.0)) (PRN (-LRB- -LRB-) (NP (CD 81.8-82.3)) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))))))))))) (. .))
(S (ADVP (RB Interestingly)) (, ,) (NP (PRP$ our) (NN approach)) (VP (VP (VBZ offers) (NP (NP (JJ additional) (NNS strengths)) (PP (IN over) (NP (NP (DT the) (VBG existing) (JJ clinical) (NNS standards)) (PP (IN in) (NP (NNP AMD) (NN prognosis))))) (PRN (-LRB- -LRB-) (NP (NN e.g.)) (, ,) (NP (NP (NN risk) (NN ascertainment)) (PP (IN above) (NP (CD 50) (NN %)))) (-RRB- -RRB-)))) (CC and) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (RB highly) (JJ generalizable)))))) (, ,) (PP (VBN given) (NP (NP (DT the) (NN breadth)) (PP (IN of) (NP (NP (VBG training) (NNS data)) (PP (IN from) (NP (CD 82) (NNP US) (JJ retinal) (NN specialty) (NNS clinics))))))))) (. .))
(S (ADVP (RB Indeed)) (, ,) (PP (IN during) (NP (NP (JJ external) (NN validation)) (PP (IN through) (NP (NP (NP (NN training)) (PP (IN on) (NP (NNP AREDS)))) (CC and) (NP (NP (VBG testing)) (PP (IN on) (NP (NNP AREDS2))) (PP (IN as) (NP (DT an) (JJ independent) (NN cohort)))))))) (, ,) (NP (PRP$ our) (NN model)) (VP (VBD retained) (NP (NP (ADJP (RB substantially) (JJR higher)) (JJ prognostic) (NN accuracy)) (PP (IN than) (NP (VBG existing) (JJ clinical) (NNS standards))))) (. .))
(S (NP (DT These) (NNS results)) (VP (VBD highlight) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (JJ deep) (VBG learning) (NNS systems))) (S (VP (TO to) (VP (VB enhance) (NP (NP (JJ clinical) (NN decision-making)) (PP (IN in) (NP (NNP AMD) (NNS patients))))))))) (. .))
